<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01131481</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol Number 7248</org_study_id>
    <nct_id>NCT01131481</nct_id>
  </id_info>
  <brief_title>Evaluation of Glistenings in Intraocular Lenses Implanted in Normal Patients Following Routine Cataract Extraction.</brief_title>
  <acronym>AVS Vs MA50BM</acronym>
  <official_title>Evaluation of Glistenings in Intraocular Lenses AVS Model X-60 Vs AcrySof MA50-BM.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fry Eye Associates and Fry Eye Surgery Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bausch &amp; Lomb Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Fry Eye Associates and Fry Eye Surgery Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of glistenings in intraocular lenses implanted in normal patients following
      routine cataract surgery. The lenses used will be Model X-60 made by the AVS company Vs
      AcrySof MA50BM made by the Alcon company.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    lack of recruitment
  </why_stopped>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">July 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of Glistenings between the Model X-60 made by the AVS company and AcrySof MA50BM made by the Alcon company.</measure>
    <time_frame>The patient will be followed 1-2 days after surgery on the first eye and 1-2 days after surgery on the second eye,1-2 months after surgery on both eyes,4-6 months after surgery on both eyes and 1,2 and 3 yrs after surgery on both eyes.</time_frame>
    <description>Each patient will have the same testing at each visit. Photos will be taken of the glistenings,sent off and counted.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Glistenings</condition>
  <arm_group>
    <arm_group_label>AcrySof MA50BM,AVS Model X-60</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>AcrySof MA50BM, AVS Model X-60</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraocular lens</intervention_name>
    <arm_group_label>AcrySof MA50BM,AVS Model X-60</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Bilateral cataracts requiring surgery

          -  Potential visual acuity of 20/40 or better in both eyes

          -  Require IOL power in range of 15-25 diopters

          -  Pupillary dilation of at least 6mm

          -  Willing and able to provide informed consent and attend follow-up appointments to 3
             years

        Exclusion Criteria:

          -  Any co-existing ocular disease or previous ocular surgery that would confound findings
             in the study, especially those effecting quality of vision. Examples include Macular
             degeneration amblyopia and prior epiretinal membrane peel.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luther Fry, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fry Eye Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fry Eye Associates</name>
      <address>
        <city>Garden City</city>
        <state>Kansas</state>
        <zip>67846</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2010</study_first_submitted>
  <study_first_submitted_qc>May 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 27, 2010</study_first_posted>
  <last_update_submitted>September 14, 2015</last_update_submitted>
  <last_update_submitted_qc>September 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 15, 2015</last_update_posted>
  <responsible_party>
    <name_title>Luther L. Fry,M.D.</name_title>
    <organization>Fry Eye Associates and Fry Eye Surgery Center</organization>
  </responsible_party>
  <keyword>cataracts,glistenings,intraocular lenses.</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

